ZBH — ZIMMER BIOMET HOLDINGS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About ZIMMER BIOMET HOLDINGS INC (ZBH)
ZIMMER BIOMET HOLDINGS INC (ZBH) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $145M. Across recent filings, tracked investors recorded 0 new positions, 2 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ZBH
How many top investors track ZBH
A small number of top investors own this.
ZBH Ownership Composition
How ZIMMER BIOMET HOLDINGS INC is held across tracked investor types, based on reported 13F positions.
- Other96.8%
- Hedge Funds3.2%
Tracked investors reporting ZBH
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.6MValue$144.9M% Portfolio0.02%
- Izzy EnglanderDec 31, 2025Millennium ManagementShares442.8KValue$39.8M% Portfolio0.02%
- Steve CohenDec 31, 2025Point72 Asset ManagementShares68.8KValue$6.2M% Portfolio0.01%
- Ray DalioMar 31, 2026Bridgewater AssociatesShares34KValue$3.1M% Portfolio0.01%
Recent activity
- Increased$3.1M(8.85%)May 15, 2026
- Increased$2.8M(148.85%)Feb 13, 2026
Frequently asked questions
- How many institutional investors hold ZBH?
- 4 tracked institutional investors disclosed a position in ZBH (ZIMMER BIOMET HOLDINGS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ZBH?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ZBH, valued at $145M.
- Did institutional ownership of ZBH increase or decrease?
- Across recent 13F filings, tracked investors recorded 0 new positions, 2 increased, 0 reduced, and 0 fully exited ZBH.
- Where does this ZBH ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.